Time to treat polycystic kidney diseases like the neoplastic disorders that they are
- 1 January 2000
- journal article
- Published by Elsevier in Kidney International
- Vol. 57 (1) , 339-340
- https://doi.org/10.1046/j.1523-1755.2000.00849.x
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Treatment of polycystic kidney disease with a novel tyrosine kinase inhibitorKidney International, 2000
- In vitro modulation of cyst formation by a novel tyrosine kinase inhibitorKidney International, 1999
- New insights into the molecular pathophysiology of polycystic kidney diseaseKidney International, 1999
- New insights into polycystic kidney disease and its treatmentCurrent Opinion in Nephrology and Hypertension, 1998
- Efficacy of taxol in the orpk mouse model of polycystic kidney diseasePediatric Nephrology, 1997
- The effect of paclitaxel on the progression of polycystic kidney disease in rodentsAmerican Journal of Kidney Diseases, 1997
- Epidermal Growth Factor Ameliorates Autosomal Recessive Polycystic Kidney Disease in MiceDevelopmental Biology, 1995
- Taxol inhibits progression of congenital polycystic kidney diseaseNature, 1994
- Murine Infantile Polycystic Kidney Disease: A Role for Reduced Renal Epidermal Growth FactorAmerican Journal of Kidney Diseases, 1991
- Renal epithelial fluid secretion and cyst growth: the role of cyclic AMPThe FASEB Journal, 1989